股票 › INBX
英伯克斯生物科技 INBX
美股市值排名 #3072
$84.52 +$4.24 (+5.28%)
休市 · Nov 6, 8:10 pm ET · 最新盘后价 $82.41 -2.50%
开盘$80.68
昨收$80.28
当日区间$79.47 – $85.58
成交量220.2K
市值$1.24B
市盈率（TTM）–
股息率–
基本面
最新报告季度：Q2, ended Jun 2026
营收$0.00-100.0% YoY
营业利润-$32.15M-17.4% YoY
净利润-$36.65M-27.9% YoY
摊薄每股收益-$2.34-26.5% YoY
自由现金流-$29.92M+0.1% YoY
经营现金流-$29.92M
营收，近8个季度
净利润，近8个季度
各季度摊薄每股收益
各季度自由现金流
年度营收
盈利能力与资产负债表
净资产收益率-1,773.6%
资产收益率-75.4%
投入资本回报率-86.9%
流动比率5.07
负债/资产比率134.4%
现金及投资$133.34M
总负债$179.14M
净现金（净负债）-$45.79M
利润表
| 项目 | 2026 Q2 | 2026 Q1 | 2025 ANNUAL | 2025 Q4 | 2025 Q3 |
|---|---|---|---|---|---|
| 报告营业总收入 | $0.00 | – | $1.30M | $0.00 | $0.00 |
| 营业总收入 | $0.00 | $0.00 | $1.30M | $0.00 | $0.00 |
| 营业费用 | $32.15M | $30.93M | $136.33M | $30.92M | $33.81M |
| 销售及管理费用 | $8.25M | $5.71M | $23.12M | $5.40M | $5.28M |
| -管理费用 | $8.25M | $5.71M | $23.12M | $5.40M | $5.28M |
| 研发费用 | $23.90M | $25.22M | $113.03M | $25.35M | $28.54M |
| 营业利润 | -$32.15M | -$30.93M | -$135.03M | -$30.92M | -$33.81M |
| 非经营性利息净收入（支出） | -$4.43M | -$2.50M | -$4.65M | -$1.87M | -$1.40M |
| 非经营性利息收入 | $1.26M | $1.01M | $7.55M | $1.31M | $1.78M |
| 非经营性利息支出 | $5.69M | $3.51M | $12.20M | $3.19M | $3.18M |
| 其他收入（支出） | -$68,000.00 | -$12,000.00 | -$381,000.00 | -$39,000.00 | -$46,000.00 |
| 其他非经营性收入（支出） | -$68,000.00 | -$12,000.00 | -$381,000.00 | -$39,000.00 | -$46,000.00 |
| 税前利润 | -$36.65M | -$33.44M | -$140.05M | -$32.83M | -$35.26M |
| 税费 | $3,000.00 | $0.00 | $2,000.00 | $0.00 | $0.00 |
| 净利润 | -$36.65M | -$33.44M | -$140.06M | -$32.83M | -$35.26M |
| 持续经营利润 | -$36.65M | -$33.44M | -$140.06M | -$32.83M | -$35.26M |
| 归属母公司净利润 | -$36.65M | -$33.44M | -$140.06M | -$32.83M | -$35.26M |
| 归属普通股股东净利润 | -$36.65M | -$33.44M | -$140.06M | -$32.83M | -$35.26M |
| 基本每股收益 | -$2.34 | -$2.15 | -$9.04 | -$2.11 | -$2.28 |
| 摊薄每股收益 | -$2.34 | -$2.15 | -$9.04 | -$2.11 | -$2.28 |
| 折旧、摊销与折耗 | – | – | $179,000.00 | – | – |
| -折旧与摊销 | – | – | $179,000.00 | – | – |
| 特殊收益（费用） | – | – | $0.00 | $0.00 | $0.00 |
| -减：重组及并购费用 | – | – | $0.00 | $0.00 | $0.00 |
资产负债表
| 项目 | 2026 Q2 | 2026 Q1 | 2025 ANNUAL | 2025 Q4 | 2025 Q3 |
|---|---|---|---|---|---|
| 总资产 | $154.22M | $183.97M | $146.48M | $146.48M | $177.47M |
| 流动资产合计 | $142.21M | $171.34M | $132.83M | $132.83M | $161.42M |
| 现金及现金等价物与短期投资 | $133.34M | $161.66M | $124.22M | $124.22M | $153.09M |
| -现金及现金等价物 | $133.34M | $161.66M | $124.22M | $124.22M | $153.09M |
| 应收款 | $132,000.00 | $186,000.00 | $177,000.00 | $177,000.00 | $837,000.00 |
| -其他应收款 | $132,000.00 | $186,000.00 | $177,000.00 | $177,000.00 | $727,000.00 |
| 预付资产 | $7.12M | $7.85M | $6.89M | $6.89M | $5.80M |
| 其他流动资产 | $1.62M | $1.65M | $1.54M | $1.54M | $1.70M |
| 非流动资产合计 | $12.01M | $12.63M | $13.65M | $13.65M | $16.05M |
| 固定资产净值 | $7.24M | $8.25M | $9.27M | $9.27M | $10.31M |
| -固定资产原值 | $19.40M | $19.91M | $20.39M | $20.39M | $20.89M |
| -累计折旧 | -$12.16M | -$11.66M | -$11.12M | -$11.12M | -$10.58M |
| 其他非流动资产 | $4.77M | $4.38M | $4.38M | $4.38M | $5.74M |
| 负债合计 | $207.20M | $205.00M | $138.49M | $138.49M | $140.64M |
| 流动负债合计 | $28.06M | $26.51M | $33.80M | $33.80M | $35.98M |
| 应付款 | $9.80M | $8.76M | $5.94M | $5.94M | $6.77M |
| -应付账款 | $9.80M | $8.76M | $5.94M | $5.94M | $6.77M |
| 一年内应计费用 | $11.92M | $13.10M | $18.08M | $18.08M | $22.13M |
| 短期债务及融资租赁负债 | $2.49M | $2.41M | $2.33M | $2.33M | $2.25M |
| -一年内到期融资租赁负债 | $2.49M | $2.41M | $2.33M | $2.33M | $2.25M |
| 非流动负债合计 | $179.14M | $178.49M | $104.69M | $104.69M | $104.66M |
| 长期债务及融资租赁负债 | $179.14M | $178.49M | $104.69M | $104.69M | $104.66M |
| -长期债务 | $176.29M | $174.99M | $100.56M | $100.56M | $99.92M |
| -长期融资租赁负债 | $2.85M | $3.50M | $4.13M | $4.13M | $4.74M |
| 股东权益合计 | -$52.98M | -$21.04M | $7.99M | $7.99M | $36.83M |
| 股东权益 | -$52.98M | -$21.04M | $7.99M | $7.99M | $36.83M |
| 股本 | $1,000.00 | $1,000.00 | $1,000.00 | $1,000.00 | $1,000.00 |
| -普通股 | $1,000.00 | $1,000.00 | $1,000.00 | $1,000.00 | $1,000.00 |
| -优先股 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| 资本公积 | $263.30M | $258.59M | $254.18M | $254.18M | $250.18M |
| 留存收益 | -$316.28M | -$279.63M | -$246.19M | -$246.19M | -$213.35M |
| -应收账款 | – | – | $0.00 | $0.00 | $110,000.00 |
| -一年内应收关联方款项 | – | – | $0.00 | $0.00 | $0.00 |
现金流量表
| 项目 | 2026 Q2 | 2026 Q1 | 2025 ANNUAL | 2025 Q4 | 2025 Q3 |
|---|---|---|---|---|---|
| 经营活动现金流 | -$29.92M | -$38.03M | -$129.79M | -$30.12M | -$33.82M |
| 持续经营经营活动现金流净额 | -$29.92M | -$38.03M | -$129.79M | -$30.12M | -$33.82M |
| 持续经营净利润 | -$36.65M | -$33.44M | -$140.06M | -$32.83M | -$35.26M |
| 折旧、折耗与摊销 | $523,000.00 | $537,000.00 | $2.48M | $564,000.00 | $583,000.00 |
| 其他非现金项目 | $1.79M | $1.22M | $4.24M | $1.11M | $1.09M |
| 营运资金变动 | $1.30M | -$8.99M | -$7.61M | -$1.72M | -$3.42M |
| -应收款变动 | $54,000.00 | -$9,000.00 | $243,000.00 | $660,000.00 | $130,000.00 |
| -预付资产变动 | $371,000.00 | -$1.06M | $1.40M | $423,000.00 | $25,000.00 |
| -应付账款及应计费用变动 | $1.44M | -$7.37M | -$7.66M | -$2.26M | -$3.03M |
| -其他流动资产变动 | $0.00 | $0.00 | $0.00 | $0.00 | -$22,000.00 |
| -其他流动负债变动 | -$563,000.00 | -$549,000.00 | -$1.60M | -$535,000.00 | -$522,000.00 |
| 投资活动现金流净额 | $0.00 | $0.00 | -$28,000.00 | $0.00 | -$7,000.00 |
| 持续经营投资活动现金流净额 | $0.00 | $0.00 | -$28,000.00 | $0.00 | -$7,000.00 |
| 固定资产购置及出售净额 | $0.00 | $0.00 | -$28,000.00 | $0.00 | -$7,000.00 |
| 筹资活动现金流 | $1.60M | $75.46M | $101.45M | $1.25M | $352,000.00 |
| 持续经营筹资活动现金流净额 | $1.60M | $75.46M | $101.45M | $1.25M | $352,000.00 |
| 债务发行及偿还净额 | $0.00 | $74.99M | $99.97M | $0.00 | $0.00 |
| 股票期权行使所得 | $1.60M | $471,000.00 | $1.61M | $1.25M | $352,000.00 |
| 期末现金余额 | $133.34M | $161.66M | $124.22M | $124.22M | $153.09M |
| 现金净变动 | -$28.31M | $37.44M | -$28.38M | -$28.87M | -$33.48M |
| 期初现金余额 | $161.66M | $124.22M | $152.60M | $153.09M | $186.57M |
| 自由现金流 | -$29.92M | -$38.03M | -$129.83M | -$30.12M | -$33.83M |
| 持续经营损益 | – | – | $12,000.00 | $9,000.00 | – |
| 其他筹资费用净额 | – | – | -$125,000.00 | $0.00 | $0.00 |
暂无评论——快来第一个聊聊 INBX。
登录后参与讨论。